Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Enhanced NF-kappa B signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
QMRO Home
William Harvey Research Institute
Centre for Clinical Pharmacology
Enhanced NF-kappa B signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
QMRO Home
William Harvey Research Institute
Centre for Clinical Pharmacology
Enhanced NF-kappa B signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors